2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Shareholder Vote Results from Merck & Co., Inc. Annual Meeting
Reports First Quarter 2025 Financial Results
Consolidated Statement of Income - GAAP
Other Events
News, Securities Holder Rights or Indentures, Description of Registrant's Securities, Legal Opinion
Reports Q2 2025 Financial Results
Shareholder votes
Q1
FY 2024
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Tender Offer Statement by Third Party
Definitive Proxy Statement
Additional Proxy Materials
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Annual Report of Employee Stock Purchase
Specialized Disclosure Report
Free Writing Prospectus
Amended Tender Offer Statement by Third Party